See also this year's filing and all EDGAR filings for this company.
PDF Report 0000320017_2026_Lisata_Therapeutics_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000320017, Lisata Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 23,000 |
| 2 | AssetsCurrent | 17,703,000 |
| 3 | PropertyPlantAndEquipment | 18,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 72,000 |
| 6 | LiabilitiesCurrent | 3,071,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 10,430,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 6,987,000 |
| 17 | remainder_Revenues | 170,000 |
| 18 | remainder_NetIncome | 661,000 |
| 19 | remainder_ComprehensiveNetIncome | 44,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,744,000 |
| 1 | Liabilities | 3,143,000 |
| 2 | Expenses | 17,417,000 |
| 3 | Revenues | 170,000 |
| 4 | StockholdersEquity | 14,601,000 |
| 5 | NetIncome | -16,586,000 |
| 6 | ComprehensiveNetIncome | -16,542,000 |
| 7 | BaseVar | 19,589,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.443 |
| 9 | EconomicCapitalRatio | 1.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
